Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Immune pathways and genetic factors in SAPHO syndrome

Official title: Study of the Pathophysiological Mechanisms Involved in the SAPHO Syndrome: Genetic Component and Immune Response

Run by Fondation Hôpital Saint-Joseph · NCT07081880 · Data updated 2026-11-12

This project will test whether specific immune cell patterns and genetic differences in adults with SAPHO syndrome are linked to the disease by collecting blood and other biological samples.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorFondation Hôpital Saint-Joseph
Academic / other
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedJuly 15, 2025
Main results expectedJuly 15, 2028
Study endsMay 15, 2035
Registry record updatedDecember 24, 2025
Trial IDNCT07081880 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with a confirmed diagnosis of SAPHO syndrome who can give informed written consent, are French-speaking, weigh over 35 kg, and can attend the participating Paris hospitals.

Probably not a fit

Because this is an observational biological-sampling study, participants should not expect direct therapeutic benefit, and pregnant or breastfeeding people and those under legal protection are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will enroll adults with a confirmed diagnosis of SAPHO syndrome at two Paris hospitals to collect biological samples for laboratory study. Researchers will perform deep immune phenotyping of circulating leukocytes—focusing on neutrophil subsets, neutrophil extracellular traps (NETs), and Th17 cells—alongside protein profiling. The study will also conduct genetic analyses to search for variants associated with SAPHO in a European/Caucasian population, addressing gaps from prior smaller or non-European studies. Results will help identify over- or under-represented cell populations and candidate genes that may contribute to disease mechanisms.

Why it matters

Potential benefit: If successful, this work could identify clearer diagnostic markers and point to new targets for treatments tailored to people with SAPHO.

How similar studies have gone: Prior smaller studies have reported increased Th17 cells, low-density granulocytes, NET formation, and some genetic links (for example IL-23R and IL-4 in Chinese cohorts), but comprehensive circulating immune phenotyping and large-scale genetic analysis in European patients remain novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged ≥ 18 years
* Patient diagnosed with SAPHO syndrome
* Weight \> 35 kg
* Patient affiliated with a health insurance plan
* French-speaking patient
* Patient who has given free, informed, and written consent

Exclusion Criteria:

* Patient under guardianship or curatorship
* Patient deprived of liberty
* Patient under legal protection
* Pregnant or breastfeeding patient

Where it's running

  • Hôpital Cochin
    Paris, France
    Recruiting
  • Hôpital Paris Saint Joseph
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.